Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Interpace Biosciences Inc IDXG

Healthcare
Interpace Biosciences, Inc. provides personalized medicine and offers specialized services along the therapeutic value chain from early diagnosis and prognostic planning to targeted therapeutic applications. Its clinical services, through Interpace Diagnostics, provide clinically useful molecular diagnostic tests, bioinformatics and pathology services for evaluating the risk of cancer by... see more

Recent & Breaking News (OTCQX:IDXG)

Interpace Diagnostics Labs Receive College of American Pathology (CAP) Accreditation

GlobeNewswire April 25, 2019

Interpace Diagnostics Announces New York State Approval

GlobeNewswire April 23, 2019

Interpace Diagnostics Announces New Coverage of Thyroid Testing by Medica

GlobeNewswire April 2, 2019

Interpace Diagnostics Group Reports Full Year and Fourth Quarter 2018 Financial Results

GlobeNewswire March 19, 2019

Interpace Diagnostics Receives Regional Award as 2018 Top Life Sciences Company

GlobeNewswire March 4, 2019

Interpace Diagnostics Announces Preliminary 2018 Revenues

GlobeNewswire February 28, 2019

Interpace Diagnostics Announces First Independent Publication Demonstrating Clinical Utility of BarreGEN®

GlobeNewswire February 19, 2019

Interpace Diagnostics to Attend BIO CEO & Investor Conference in New York City

GlobeNewswire February 4, 2019

 Interpace Diagnostics Announces Closing of $7.0 Million Public Offering of Common Stock

GlobeNewswire January 29, 2019

Interpace Diagnostics Announces Pricing of $7.0 Million Public Offering of Common Stock

GlobeNewswire January 25, 2019

Interpace Diagnostics Announces Proposed Public Offering of Common Stock

GlobeNewswire January 24, 2019

Interpace Diagnostics to Present at the Fifteenth Annual NobleCon

GlobeNewswire January 24, 2019

Interpace Diagnostics Announces Further Expansion of Thyroid Business

GlobeNewswire January 22, 2019

Interpace Diagnostics Enters into Agreement with University of Maryland Medical System

GlobeNewswire January 14, 2019

Interpace Diagnostics Ranked as Top 10 Bioinformatics Solutions Provider

GlobeNewswire December 27, 2018

Interpace Announces Notice of Allowance from U.S. Patent and Trademark Office Covering BarreGEN®

GlobeNewswire December 17, 2018

Detailed Research: Economic Perspectives on PayPal, Alphabet, Southern, Interpace Diagnostics Group, Edwards Lifesciences, and Laboratory Corporation of America — What Drives Growth in Today's Competitive Landscape

GlobeNewswire December 7, 2018

Interpace Diagnostics Launches New Websites

GlobeNewswire November 28, 2018

Newly Published Data from National Study Supports Interpace Diagnostics’ PancraGEN®

GlobeNewswire November 26, 2018

Interpace Diagnostics Reports Third Quarter 2018 Financial Results, Business Progress and Recent Accomplishments

GlobeNewswire November 13, 2018